Vaxart Pushes Ahead With IND Filing for COVID-19 Vaccine Candidate
Coronavirus stock Vaxart (NASDAQ: VXRT) did well on Monday, following the company's latest piece of news regarding its COVID-19 vaccine candidate. The company announced that it filed an Investigational New Drug (IND) application for the candidate.
An IND application is chiefly a request for permission to begin testing a treatment or vaccine on human subjects. Out of an original five it was developing, Vaxart's vaccine candidate is the one the company has chosen for further development. It is unique among current vaccine candidates in that it is the only one that can be taken orally.
Image source: Getty Images.
Source Fool.com
